Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEntain Regulatory News (ENT)

Share Price Information for Entain (ENT)

Share Price is delayed by 15 minutes
Get Live Data
555.80    0.40 (0.07%)
Bid:
555.40
Ask:
556.20
Spread: 0.80 (0.144%)
Market Cap: £3.56b
ENT Live PriceLast checked at - London Stock Exchange

Intraday Entain Share Chart

Form 8.3 - DraftKings Inc

8 Oct 2021 14:52

RNS Number : 5468O
D E Shaw & Co LP
08 October 2021
Β 

FORM 8.3

Β 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Full name of discloser:

D. E. Shaw & Co., L.P.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

DraftKings Inc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

October 07, 2021

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes, the discloser has previously made disclosures in respect of Entain plc

Β 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Β 

Class of relevant security:

Β 

USD 0.0001 class A common

Β 

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

516,588

0.12%

2,113,272

0.52%

(2) Cash-settled derivatives:

Β 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

978,500

0.24%

2,176,400

0.53%

Β 

TOTAL:

1,495,088

0.36%

4,283,376

1.05%

Β 

Β 

Β 

Β 

Β 

Class of relevant security:

Convertible Senior Notes 2028

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Β 49,500,000

3.91%

(2) Cash-settled derivatives:

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

TOTAL:

49,500,000

3.91%

Β 

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental FormΒ 8 (Open Positions).

Β 

(b) Rights to subscribe for new securities (including directors' and other employee options)

Β 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

Β 

Β 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchase/sale

Β 

Number of securities

Price per unit

USD 0.0001 class A common

Sale

100

USD 50.60

USD 0.0001 class A common

Sale

100

USD 50.62

USD 0.0001 class A common

Sale

100

USD 50.67

USD 0.0001 class A common

Sale

1,100

USD 50.70

USD 0.0001 class A common

Sale

600

USD 50.71

USD 0.0001 class A common

Sale

300

USD 50.72

USD 0.0001 class A common

Sale

200

USD 50.73

USD 0.0001 class A common

Sale

615

USD 50.75

USD 0.0001 class A common

Sale

100

USD 50.76

USD 0.0001 class A common

Sale

900

USD 50.77

USD 0.0001 class A common

Sale

700

USD 50.78

USD 0.0001 class A common

Sale

100

USD 50.79

USD 0.0001 class A common

Sale

608

USD 50.80

USD 0.0001 class A common

Sale

300

USD 50.81

USD 0.0001 class A common

Sale

300

USD 50.82

USD 0.0001 class A common

Sale

700

USD 50.83

USD 0.0001 class A common

Sale

700

USD 50.84

USD 0.0001 class A common

Sale

500

USD 50.85

USD 0.0001 class A common

Sale

100

USD 50.86

USD 0.0001 class A common

Sale

1,410

USD 50.87

USD 0.0001 class A common

Sale

100

USD 50.88

USD 0.0001 class A common

Sale

1,263

USD 50.89

USD 0.0001 class A common

Sale

200

USD 50.90

USD 0.0001 class A common

Sale

200

USD 50.91

USD 0.0001 class A common

Sale

600

USD 50.93

USD 0.0001 class A common

Sale

400

USD 50.94

USD 0.0001 class A common

Sale

100

USD 50.96

USD 0.0001 class A common

Sale

300

USD 50.97

USD 0.0001 class A common

Sale

100

USD 50.98

USD 0.0001 class A common

Sale

300

USD 50.99

Β 

(b) Cash-settled derivative transactions

Β 

Β 

Class of relevant security

Product description e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Β 

Β 

(c) Stock-settled derivative transactions (including options)

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Β 

Β 

Β 

Β 

Β 

(ii) Exercise

Β 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

Β 

Β 

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

Β 

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

Β 

Β 

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

Β 

Β 

Β 

(c) Attachments

Β 

Is a Supplemental Form 8 (Open Positions) attached?

Yes

Β 

Β 

Date of disclosure:

October 08, 2021

Contact name:

Kevin Krist (Compliance Department)

Telephone number*:

+44 (0) 20 7409 4420

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

Β 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

Β 

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the "Code")

Β 

Β 

1. KEY INFORMATION

Β 

Full name of person making disclosure:

D. E. Shaw & Co., L.P.

Name of offeror/offeree in relation to whose relevant securities the disclosure relates:

DraftKings Inc

Β 

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Β 

Class of relevant security

Product description e.g. call option

Written or purchased

Number of securities to which option or derivative relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

USD 0.0001 class A common

Listed Call Option

Purchased

190,000

USD 70.0

American

20211015

USD 0.0001 class A common

Listed Call Option

Purchased

60,000

USD 100.0

American

20211015

USD 0.0001 class A common

Listed Call Option

Purchased

110,000

USD 100.0

American

20220121

USD 0.0001 class A common

Listed Call Option

Purchased

120,000

USD 90.0

American

20220414

USD 0.0001 class A common

Listed Call Option

Purchased

10,000

USD 65.0

American

20220414

USD 0.0001 class A common

Listed Call Option

Purchased

80,000

USD 95.0

American

20230120

USD 0.0001 class A common

Listed Call Option

Purchased

100,000

USD 90.0

American

20230120

USD 0.0001 class A common

Listed Call Option

Purchased

45,000

USD 105.0

American

20230120

USD 0.0001 class A common

Listed Call Option

Written

190,000

USD 60.0

American

20211119

USD 0.0001 class A common

Listed Call Option

Written

330,000

USD 65.0

American

20220121

USD 0.0001 class A common

Listed Call Option

Written

87,400

USD 65.0

American

20230120

USD 0.0001 class A common

Listed Put Option

Purchased

170,000

USD 30.0

American

20211015

USD 0.0001 class A common

Listed Put Option

Purchased

40,000

USD 50.0

American

20211119

USD 0.0001 class A common

Listed Put Option

Purchased

150,000

USD 45.0

American

20220121

USD 0.0001 class A common

Listed Put Option

Purchased

146,000

USD 40.0

American

20220121

USD 0.0001 class A common

Listed Put Option

Purchased

150,000

USD 35.0

American

20220121

USD 0.0001 class A common

Listed Put Option

Purchased

45,000

USD 40.0

American

20220414

USD 0.0001 class A common

Listed Put Option

Purchased

200,000

USD 45.0

American

20220414

USD 0.0001 class A common

Listed Put Option

Purchased

130,000

USD 40.0

American

20220520

USD 0.0001 class A common

Listed Put Option

Purchased

28,000

USD 50.0

American

20220715

USD 0.0001 class A common

Listed Put Option

Purchased

120,000

USD 30.0

American

20220715

USD 0.0001 class A common

Listed Put Option

Purchased

70,000

USD 30.0

American

20230120

USD 0.0001 class A common

Listed Put Option

Purchased

150,000

USD 40.0

American

20230120

USD 0.0001 class A common

Listed Put Option

Purchased

160,000

USD 45.0

American

20230120

USD 0.0001 class A common

Listed Put Option

Purchased

10,000

USD 50.0

American

20230120

USD 0.0001 class A common

Listed Put Option

Written

218,700

USD 60.0

American

20211119

USD 0.0001 class A common

Listed Put Option

Written

44,800

USD 60.0

American

20230120

Β 

3. AGREEMENTS TO PURCHASE OR SELL ETC.

Β 

Full details should be given so that the nature of the interest or position can be fully understood:

Β 

Β 

Β 

Β 

Β 

Β 

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETUWOORASURRAA
Date   Source Headline
13th Nov 20257:00 amRNSPricing of €500 million Senior Secured Notes
10th Nov 20258:00 amRNSProposed Refinancing Transaction
6th Nov 20253:10 pmRNSDirector/PDMR Shareholding
3rd Nov 202510:00 amRNSTotal Voting Rights
15th Oct 20257:00 amRNSQ3 Trading Update
14th Oct 202512:00 pmRNSBetMGM Q3 2025 Update and Raised FY25 Guidance
14th Oct 20258:59 amRNSTR1: Notification of Major Holdings
1st Oct 20257:01 amRNSBlock Listing Six Monthly Return
1st Oct 20257:00 amRNSTotal Voting Rights
5th Sep 20252:44 pmRNSDirector/PDMR Shareholding
1st Sep 20257:00 amRNSTotal Voting Rights
12th Aug 20257:01 amRNSInterim Results
12th Aug 20257:00 amRNSAppointment of Non-Executive Chair
1st Aug 20257:00 amRNSTotal Voting Rights
31st Jul 20257:00 amRNSSuccessful repricing and extension of Term Loans
29th Jul 20257:00 amRNSBETMGM 2Q/1H 2025 UPDATE & FY25 GUIDANCE INCREASE
3rd Jul 20252:00 pmRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSTotal Voting Rights
30th Jun 20259:00 amRNS-RNew Zealand Government Establishes Legislative Net
16th Jun 20257:00 amRNSBetMGM - Upgraded FY 2025 Guidance
4th Jun 20259:48 amRNSDirector/PDMR Shareholding
2nd Jun 202510:26 amRNSTotal Voting Rights
15th May 20257:00 amRNSBoard Appointments
6th May 202512:34 pmRNSDirector/PDMR Shareholding
1st May 20257:00 amRNSTotal Voting Rights
29th Apr 20257:01 amRNSQ1 Trading Update
29th Apr 20257:00 amRNSAppointment of Chief Executive Officer
28th Apr 202512:00 pmRNSBetMGM Q1 2025 Update
23rd Apr 202511:59 amRNSResult of AGM
4th Apr 202510:20 amRNSTR1: Notification of Major Holdings
3rd Apr 20259:35 amRNSDirector/PDMR Shareholding
1st Apr 20257:01 amRNSBlock Listing Six Monthly Return
1st Apr 20257:00 amRNSTotal Voting Rights
21st Mar 20254:33 pmRNSAnnual Report, AGM and Directorate Change
19th Mar 202510:39 amRNSDirector/PDMR Shareholding
17th Mar 20259:46 amRNSTR1: Notification of Major Holdings
10th Mar 20252:24 pmRNSDirector/PDMR Shareholding
6th Mar 20257:00 amRNSFinal Results
3rd Mar 20257:00 amRNSTotal Voting Rights
14th Feb 20251:52 pmRNSDirectorate and Board Committee Changes
14th Feb 202510:49 amRNSTR1: Notification of Major Holdings
11th Feb 20257:00 amRNSDirectorate Change
4th Feb 202512:00 pmRNSBETMGM FY 2024 Update
31st Jan 20257:00 amRNSTR1: Notification of Major Holdings
13th Jan 20257:00 amRNSReiteration of FY24 EBITDA guidance
6th Jan 20259:06 amRNSDirector/PDMR Shareholding
3rd Jan 202512:04 pmRNSBlock Listing Six Monthly Return
2nd Jan 20257:50 amRNSTotal Voting Rights
17th Dec 20247:00 amRNSBlock Listing Application
16th Dec 20247:00 amRNSAcknowledgement of AUSTRAC Proceedings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.